Open AccessAdalimumab with Methotrexate in Treatment-Naïve Japanese Patients with Rheumatoid Arthritis at Risk of Progressive Structural Joint Damage: A Postmarketing Observational Study
Author(s) -
Yukiko Ito,
Kaori Hozumi,
Yukiko Okada,
Sarina Kurimoto
Publication year - 2017
Publication title -
rheumatology and therapy
Language(s) - English
Resource type - Journals
eISSN - 2198-6584
pISSN - 2198-6576
DOI - 10.1007/s40744-017-0059-1
Subject(s) - adalimumab , rheumatoid arthritis , medicine , methotrexate , observational study , postmarketing surveillance , dermatology , adverse effect
The objective of this study was to evaluate the real-world safety and effectiveness of adalimumab with methotrexate (MTX) in disease-modifying antirheumatic drug (DMARD)- and biologic-naïve Japanese patients with rheumatoid arthritis (RA) at risk of progressive structural joint damage.